Silver Book Fact

Cancer patients in the U.S. experience greater survival gains than those in European countries, and the value of additional gains exceeds the additional cost of care in the U.S.

Philipson T, Eber M, Lakdawalla D, Corral M, et al. An Analysis of Whether Higher Health Care Spending is Worth it in the Case of Cancer. Health Affairs. 2012; 31(4): 667-75. http://content.healthaffairs.org/content/31/4/667.abstract

Reference

Title
An Analysis of Whether Higher Health Care Spending is Worth it in the Case of Cancer
Publication
Health Affairs
Publication Date
2012
Authors
Philipson T, Eber M, Lakdawalla D, Corral M, et al.
Volume & Issue
Volume 31, Issue 4
Pages
667-75
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • The 5-year survival rate for prostate cancer has increased from 67% to nearly 100% over the past 20 years.  
  • More than half of cancer deaths in the U.S. are due to preventable causes.  
  • Use of a monocolonal antibody with adjuvant chemotherapy in HER2+ individuals with operable cancer was associated with a 33 percent reduction in risk of death.  
  • “Among women age 65 and over, the percentage who had a mammogram within the preceding 2 years almost tripled from 23% in 1987 to 64% in 2005.”  
  • Medical research that resulted in a 1/5 reduction in deaths from cancer would be worth $10 trillion to Americans-double the national debt.